BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22430335)

  • 1. Is there an ototoxicity risk from Cortisporin and comparable otic suspensions? Distortion-product otoacoustic emission findings.
    Berenholz LP; Rossi DL; Lippy WH; Burkey JM
    Ear Nose Throat J; 2012 Mar; 91(3):106-35. PubMed ID: 22430335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical otic antibiotics: clinical cochlear ototoxicity and cost consideration.
    Berenholz LP; Burkey JM; Farmer TL; Lippy WH
    Otolaryngol Head Neck Surg; 2006 Aug; 135(2):291-4. PubMed ID: 16890085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tympanostomy tubes and otic drops.
    Meyerhoff WL; Morizono T; Wright CG; Shaddock LC; Shea DA; Sikora MA
    Laryngoscope; 1983 Aug; 93(8):1022-7. PubMed ID: 6308368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.
    Schwartz RH
    Curr Med Res Opin; 2006 Sep; 22(9):1725-36. PubMed ID: 16968576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ototoxicity of otic drops applied to the middle ear in the chinchilla.
    Wright CG; Meyerhoff WL
    Am J Otolaryngol; 1984; 5(3):166-76. PubMed ID: 6331211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cochleotoxicity of otic drops in the chinchilla: comparative study of Bestron and Cortisporin.
    Ikeda K; Morizono T; Juhn SK
    Am J Otol; 1991 Nov; 12(6):429-34. PubMed ID: 1805633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ofloxacin otic drops vs neomycin-polymyxin B otic drops as prophylaxis against early postoperative tympanostomy tube otorrhea.
    Poetker DM; Lindstrom DR; Patel NJ; Conley SF; Flanary VA; Link TR; Kerschner JE
    Arch Otolaryngol Head Neck Surg; 2006 Dec; 132(12):1294-8. PubMed ID: 17178938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of ototopical antibiotics.
    Welling DB; Forrest LA; Goll F
    Laryngoscope; 1995 May; 105(5 Pt 1):472-4. PubMed ID: 7760659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of cortisporin and ciprofloxacin otic drops as prophylaxis against post-tympanostomy otorrhea.
    Morpeth JF; Bent JP; Watson T
    Int J Pediatr Otorhinolaryngol; 2001 Nov; 61(2):99-104. PubMed ID: 11589975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children.
    Rahman A; Rizwan S; Waycaster C; Wall GM
    Clin Ther; 2007 Sep; 29(9):1950-6. PubMed ID: 18035194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Water precautions in children with tympanostomy tubes.
    Salata JA; Derkay CS
    Arch Otolaryngol Head Neck Surg; 1996 Mar; 122(3):276-80. PubMed ID: 8607955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory effects of otic drops on the middle ear.
    Anderson RG; Wright CG; Meyerhoff WL
    Int J Pediatr Otorhinolaryngol; 1984 May; 7(2):91-5. PubMed ID: 6086545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of efficacy and safety of ciprofloxacin otic solution 0.2% versus polymyxin B-neomycin-hydrocortisone in the treatment of acute diffuse otitis externa*.
    Drehobl M; Guerrero JL; Lacarte PR; Goldstein G; Mata FS; Luber S
    Curr Med Res Opin; 2008 Dec; 24(12):3531-42. PubMed ID: 19032135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ototoxicity of an ototopic preparation--experimental results and clinical facts.
    Halama AR; Wright CG; Meyerhoff WL
    Acta Otorhinolaryngol Belg; 1991; 45(3):279-82. PubMed ID: 1950546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ototoxicity of ear drops: a clinical perspective.
    Linder TE; Zwicky S; Brändle P
    Am J Otol; 1995 Sep; 16(5):653-7. PubMed ID: 8588672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cortisporin otic suspension on cochlear function and efferent activity in the guinea pig.
    Perry BP; Smith DW
    Laryngoscope; 1996 Dec; 106(12 Pt 1):1557-61. PubMed ID: 8948623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generic vs. proprietary otic drops.
    Hotmes WF; Cunningham JD; Alford E
    Trans Pa Acad Ophthalmol Otolaryngol; 1989; 41():859-60. PubMed ID: 2561028
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of prophylactic otic drops after tympanostomy tube insertion.
    Ramadan HH; Tarazi T; Zaytoun GM
    Arch Otolaryngol Head Neck Surg; 1991 May; 117(5):537. PubMed ID: 2021473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ototoxicity of topical otomicrobial agents.
    Barlow DW; Duckert LG; Kreig CS; Gates GA
    Acta Otolaryngol; 1995 Mar; 115(2):231-5. PubMed ID: 7610811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic antibiotic drops after tympanostomy tube placement.
    Hester TO; Jones RO; Archer SM; Haydon RC
    Arch Otolaryngol Head Neck Surg; 1995 Apr; 121(4):445-8. PubMed ID: 7702820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.